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Dr Chumy Nwogu (Buffalo, NY). This was a very fascinating
presentation. I really enjoyed it. I have a question about how you
were able to maneuver the needle after you got it out lateral to
the arch. That seems technically difficult.
My second question is, when you are imaging with this partic-
ular linear EUS scope, it seems to me—and the illustration I
think was very helpful—that you are higher than or proximal
to the nodes. So when you are imaging, how well do you
see these nodes that are further downstream from where your
probe is?
Dr Liberman. Thank you. These are very good questions. I
will start with the second question. We completely stage the me-
diastinum on EUS after our EBUS procedure, and we start in the
belly moving upward. We evaluate the celiac access, the liver,
and the adrenal gland, and we come back for the inferior ligament
nodes. Then, when we get to the station 5 and then the station 6
nodes, we are looking at the node through the aorta, as I showed
on the picture. Once we have seen the node, we have measured it,
and we feel that it is accessible, then we pull the scope back about
4 to 5 cm above the aortic arch. At that time, we no longer see
that node.
Obviously in the images I showed you, those are the bigger no-
des, because it was easier to demonstrate in the presentation;792 The Journal of Thoracic and Cardiovascular Surghowever, a lot of the nodes in this study were smaller than that,
and they would be even harder to see in the high mediastinum.
And going along the same lines to answer your first question,
EUS, unlike EBUS, has the advantage of having a scope not
only with 2 wheels but also with a tip deflector, where the needle
itself is being bent without the scope being bent. You have a very
long needle, as long as 8 cm. You can pass that needle out into the
mediastinum.
The way we do it is that once we have decided where that node
is, we slowly pull the scope back. It depends on the patient anat-
omy, but it is usually about 20 to 25 cm from the incisors. And
then we pass the needle out into the mediastinum. The mediastinal
tissues, being rigid or somewhat rigid in the fat of the mediasti-
num, hold the needle in place, and as we advance the needle, we
turn the big wheel of the scope back and we use the tip deflector
to turn the needle forward, thus allowing us to get around the aorta.
The key is that once you have passed out into the mediastinum
just medial to the left subclavian artery, the main risk is gone. The
risk then only becomes the potential for puncture of the pleura and
possible pneumothorax, which we have not seen. But getting out
into the mediastinum outside of the vessels is the key, and once
you are out there, you have much more play and it is much easier
to do. Again, as you said, it is technically a more difficult node to
biopsy than is a station 7 or 4 or something else.
Dr Nwogu. You are implying that when you actually pass the
needle then you are not visualizing the node at that particular mo-
ment. Is that what you are saying?
Dr Liberman. Correct.
Dr Nwogu. You are using the mental image that you have from
the earlier visualization?
Dr Liberman. Correct.
Dr Nwogu. That lack of direct visualization seems to increase
the risk of the procedure a little bit.
Dr Liberman. Yes, it is a technically difficult thing to do. The
station 6 node is not a node that needs to be biopsied in most sit-
uations, but in the cases that it needs to be done, you are avoiding
a Chamberlain or a left VATS procedure. This endoscopic ap-
proach is done as an outpatient procedure. There is extremely
low risk. We have not seen any complications in our series.
And if you should get a pneumothorax, first of all, you would
see it right away on EUS; it would be easy to see. We have not
had it happen yet in this type of procedure. And it really would
not be the end of the world. Most pneumothoraces caused by
EUS do not need to be treated.
Dr David J. Sugarbaker (Boston, Mass). This is a very inter-
esting presentation, and I have 2 questions. The first is, what would
you say the learning curve is on what appears to be, as you said,
a more complex, technically demanding procedure?
Dr Liberman. Thank you. This is a very good question. This is
not the first node that you want to biopsy when you are starting
your EUS practice. We are doing a high volume, about 600 EUS
cases a year for multiple years, and we have a large experience
with EBUS. But I think that it is doable. A thoracic surgeon will
be able to do this technique a lot better and with a lot more confi-
dence and safety than, for example a gastroenterologist. I think that
the anatomy is well known to this group, and the ease or the lack of
stress in that mediastinal area for people in this room will be a lot
less than for a nonthoracic surgeon.ery c October 2012
Liberman et al General Thoracic Surgery
G
T
SBut although it is technically more difficult, I think that it is do-
able, and it is learnable. It is certainly not more difficult than
a VATS lobectomy!
Dr Sugarbaker. The other question I had is just in looking at
the positioning of the scope, have you ever thought about placing
an ultrasound bronchoscope in along with the esophagoscope so
that you could position that just across from the node and at that
point actually visualize? I think many of us are a little concerned
about passing the needle without seeing the lymph node. Have you
ever thought about doing something like that?
Dr Liberman. It is a very good question. We have done that in
other situations with multiple scopes, EBUS, EUS, in the esopha-
gus during other procedures, especially in the animal laboratory. In
this situation we have not used it, because we have not found that it
would be important in our practice. But it definitely is something
that would be an option for people who would be scared to find out
where that node is.
But do not forget, when you are doing this procedure, it is not
blind. You are following the left subclavian artery; you do see it,
and sometimes with a bigger node you will see it at the same
time as you are passing out into the mediastinum. Again, youThe Journal of Thoracic and Cahave just pulled back 1 or 2 cm; in general, you are watching the
node, it is 2 seconds later, and you see the artery, which you
know enters the aorta. The risk of the procedure I think is more
the arterial puncture and the potential pseudoaneurysm formation
or mediastinal bleeding. If you get out into the mediastinum and
then you cannot find a node, just pull your needle back and do it
again. It is a very small hole that you are making in the esophagus.
Dr Sugarbaker. I will just correct you that thoracic surgeons
are never scared—but they may be concerned.
Dr Liberman. Thank you.
Dr Charles R. Bridges (Charlotte, NC). Given that in your ab-
stract you presented only 12 patients, do you think it is a little pre-
mature to declare this procedure to be safe and reproducible?
Dr Liberman. That is a very good point. This is a very early
experience with a new technique. I know that there have been peo-
ple who have trained with us who have gone out and tried to do this
technique, somewith success and somewithout success. At least in
my experience, and from what I have heard from others, there has
been no associated morbidity, but it is too early to say, and at 12
cases I think you make a very good point. We cannot say that
this is safe in the long term.rdiovascular Surgery c Volume 144, Number 4 793
